Safety
DKA, hypoglycemic
ADVERSE EVENTS, EVENTS
During the 3-month CAS, there were no serious adverse events, DKA or severe hypoglycemic events. For the real-world cohort, system users ≤15 years of age and >15 years of age spent a mean of 7.8 min/day (54.6 min/week) and 4.8 min/day (33 min/week), respectively, at %TBR <54 mg/dL.